Brompheniramine / carbetapentane / phenylephrine Pregnancy and Breastfeeding Warnings
Brompheniramine / carbetapentane / phenylephrine is also known as: BetaTan, Pulmari, Seradex, Trexbrom (old formulation), V-COF, Vazotan
Brompheniramine / carbetapentane / phenylephrine Pregnancy Warnings
Brompheniramine/carbetapentane/phenylephrine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Brompheniramine/carbetapentane/phenylephrine is only recommended for use during pregnancy when benefit outweighs risk.
Brompheniramine / carbetapentane / phenylephrine Breastfeeding Warnings
There are no data on the excretion of brompheniramine/carbetapentane/phenylephrine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
References for pregnancy information
- "Product Information. BetaTan (brompheniramine/carbetapentane/phenylephrine)." WraSer Pharmaceuticals (2005):
References for breastfeeding information
- "Product Information. BetaTan (brompheniramine/carbetapentane/phenylephrine)." WraSer Pharmaceuticals (2005):
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.